What Axana does

Axana B.V. is a Netherlands-incorporated, UK-operating clinical software company that builds Axana MDT, an AI-powered platform supporting multidisciplinary team (MDT) processes for cancer care in hospitals. The platform addresses workflow fragmentation in oncology by aggregating patient and case data for MDT meetings, automating documentation and decision recording, verifying case readiness to reduce deferrals, issuing automated patient follow-up reminders, and monitoring patient progress against clinical pathways with proactive delay identification. The product is deployed either on-premise within hospital secure networks or via public cloud with encrypted connections, hosted in NHS England-approved data centres for UK NHS customers, and is governed under a dual Data Controller/Data Processor legal framework compliant with UK GDPR, the Data Protection Act 2018, and ICO registration.

The company is built by the team behind Aidence, which previously deployed AI solutions in over 100 UK and EU hospitals, and leverages that institutional track record as its primary credibility signal. Axana operates a subscription-based clinical software licensing model, selling directly to NHS hospital trusts through an enterprise sales motion initiated via website 'Book a demo' and 'Get in contact' CTAs; pricing is not publicly disclosed. The customer base is concentrated in UK NHS hospital trusts, with the anonymised aggregated statistical reporting capability positioned both as a benchmark for product improvement and as a potential future commercial asset. The company has no disclosed funding rounds, management team, headcount, or revenue, indicating an early-stage commercial profile.

Name

Axana

Legal name

Axana B.V.

Website

https://axana.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Axana B.V. builds Axana MDT, an AI-powered clinical software platform that supports multidisciplinary team workflows for cancer care in UK NHS hospitals. The platform automates case preparation, documentation, pathway monitoring, and patient follow-up tracking for oncology teams.

Ownership category

akta.pro rank

Product category

Clinical Decision Support Software

NAICS

Computer Systems Design Services (541512)

SIC

Services-Health Services (8000)

akta.pro primary industry

Site & Investigator Platforms (Site Payments, Feasibility, Activation) (HLACAOAJ)

Keywords

• Cancer care software
• Multidisciplinary team platform
• Oncology workflow automation
• Clinical decision support
• Healthcare AI platform

Headquarters

HQ city

Amsterdam

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Clinical Software Licensing (Axana MDT): Software licensing model for Axana MDT deployed in NHS and EU hospitals. The company acts as Data Processor when processing patient data for direct clinical care and provides IT support and regular software updates. Revenue is generated through software deployment in healthcare institutions.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Axana develops and sells Axana MDT, an AI-powered clinical software platform used by NHS and EU hospitals to support multidisciplinary team (MDT) processes in cancer care. The platform automates case preparation, data aggregation, documentation, decision recording, pathway management, and patient follow-up tracking, deployed on-premise or via secure cloud in NHS England-approved data centres.

Product overview

Axana is a unified AI-powered cancer care platform consisting of a single core product called Axana MDT. The platform provides workflow tools for cancer care including data collection, MDT preparation and optimisation, tasks and worklists, pathway management, and online collaboration. The product is designed for healthcare professionals and administrators in UK hospitals to streamline multidisciplinary team processes, reduce administrative burden, and improve patient outcomes.

Differentiator

Problem solved

Functional benefit

Brands

• Axana MDT: Clinical software product used by healthcare professionals and administrators to support multidisciplinary team (MDT) processes in UK hospitals.

Products and services

• Axana MDT Clinical software platform used by healthcare professionals and administrators in NHS and EU hospitals to support multidisciplinary team (MDT) processes for cancer care. It provides AI-powered data aggregation, case preparation, automated documentation and decision recording, pathway management, follow-up tracking, and anonymised statistical reporting, deployed on-premise within hospital secure networks or via secure cloud hosted in NHS England-approved data centres.

Quantifiable outcome

• AI-powered data aggregation reduces manual data collection time for MDT preparation
• +2 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature6 records

Scale indicators2 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• DrDoctor: DrDoctor is a UK-based patient engagement and clinical workflow platform serving NHS trusts with digital communication, appointment management, and pathway tools. It is comparable as an NHS-focused clinical workflow SaaS vendor with similar go-to-market motion and customer base (UK hospital trusts).
• Aidence: Aidence is the predecessor company founded by the same team as Axana, focused on AI-powered radiology solutions deployed in 100+ UK & EU hospitals. It is the most directly comparable peer as it shares the founding team, geographic focus, NHS customer base, and AI-for-clinical-workflows positioning—Axana explicitly markets itself as being 'from the makers of Aidence.'
• Concentric Health: Concentric Health is a UK digital health company providing clinical workflow and consent platforms deployed across NHS trusts. It is comparable as a B2B digital health vendor selling workflow software directly to NHS hospitals, operating under similar regulatory and procurement constraints as Axana.
• Optellum: Optellum is an AI-driven clinical decision support platform for lung cancer diagnosis and management, with NHS and US deployments. It is comparable as a cancer-focused AI platform serving pulmonology and oncology workflows, with similar product-led growth motion and clinical-evidence-led positioning in regulated health systems.
• C the Signs: C the Signs is a UK-based AI clinical decision support tool that helps GPs identify patients at risk of cancer at the earliest stage. It is comparable as a UK cancer-focused AI platform operating in the NHS, targeting clinical pathway optimisation and early diagnosis workflows.
• Kheiron Medical Technologies: Kheiron Medical is a UK-based AI company applying deep learning to radiology and cancer diagnostics, particularly breast cancer screening. It is comparable as a UK-headquartered clinical AI vendor with NHS deployments, targeting cancer care workflows, and operating under similar regulatory and data-compliance constraints as Axana.

Broad incumbents

• Brainlab: Brainlab is a Germany-based broader incumbent in digital surgery, oncology software, and clinical workflow platforms used in hospitals globally. It is comparable as a vendor of oncology-focused clinical software with hospital deployments, operating in adjacent workflow areas such as tumor boards and multidisciplinary oncology planning.
• Babylon Health: Babylon Health was a UK-based AI healthcare platform providing digital triage, consultations, and care navigation to NHS patients. Though it has undergone significant restructuring, it is comparable as a pioneering UK AI-health vendor operating within the NHS ecosystem and addressing clinical workflow automation.
• Huma (formerly Medopad): Huma is a UK-based digital health platform providing remote patient monitoring, digital biomarkers, and care coordination tools across multiple therapeutic areas. It is a broader incumbent with larger funding and a wider portfolio, but overlaps with Axana in NHS deployments and clinical care coordination workflows.
• Epic Systems: Epic Systems is the dominant US-based EHR vendor increasingly penetrating the NHS market (e.g., Manchester University NHS Foundation Trust) and offering oncology modules that include MDT coordination features. It is a broad incumbent that represents the primary competitive threat to Axana as integrated EHR platforms absorb specialised workflow tools.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Axana